NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) stock
NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 11/3079% below fair value
$0.71−0.04 (-5.15%)
Close on Nov 17, 2026Market cap $6.43MP/E –Yield –
Neuroone Medical Technologies profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Neuroone Medical Technologies's profit margin for the twelve months ending Jun 30, 2026 was -78.6%. For fiscal 2025 it was -39.6%, against -356.7% the year before. The highest annual figure on record is -39.6% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -39.6% | +317.1 |
| FY2024 | Sep 30, 2024 | -356.7% | +250.7 |
| FY2023 | Sep 30, 2023 | -607.4% | +5234.5 |
| FY2022 | Sep 30, 2022 | -5842.0% | −257.7 |
| FY2021 | Sep 30, 2021 | -5584.3% | −895.5 |
| FY2014 | Dec 31, 2014 | -4688.7% | −2242.5 |
| FY2013 | Dec 31, 2013 | -2446.3% | −930.5 |
| FY2012 | Dec 31, 2012 | -1515.7% | −1004.4 |
| FY2011 | Dec 31, 2011 | -511.4% | +6.5 |
| FY2010 | Dec 31, 2010 | -517.9% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | -101.7% | −13.2 |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | -127.9% | +35.8 |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | -49.7% | −104.2 |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | -59.1% | +1171.5 |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | -88.5% | +246.7 |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | -163.8% | +43.5 |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | 54.5% | +396.7 |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | -1230.6% | −807.9 |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | -335.1% | +215.5 |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | -207.3% | +548.4 |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | -342.1% | +1170.2 |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | -422.6% | +1575.3 |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | -550.7% | +8060.3 |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | -755.7% | +7603.3 |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | -1512.3% | +6806.6 |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | -1997.9% | +3470.4 |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | -8611.0% | −1249.6 |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | -8359.0% | +4765.5 |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | -8318.9% | −5577.4 |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | -5468.3% | +4782.1 |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | -7361.4% | −1411.4 |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | -13124.5% | – |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | -2741.5% | – |
| Q1 FY2015CQ1 2015 | Mar 31, 2015 | -10250.4% | – |
| Q4 FY2014CQ4 2014 | Dec 31, 2014 | -5950.0% | – |
See a number that looks wrong?